ZURICH (Reuters) - Swiss drugmaker Roche said on Monday the European Commission had approved a new formulation of its breast cancer drug Herceptin which allows the medicine to be administered more quickly.
via Reuters: Health News Read More Here..
No comments:
Post a Comment